Is Ambey Laborator. overvalued or undervalued?

As of 23 September 2025, the valuation grade for Ambey Laborator. has moved from expensive to very expensive, indicating a significant increase in perceived valuation. The company is currently considered overvalued. Key ratios include a PE Ratio of 21.92, an EV to EBITDA of 15.02, and a ROE of 6.26%.
In comparison to its peers, UPL has a PE Ratio of 38.05 and an EV to EBITDA of 9.17, while P I Industries is also very expensive with a PE of 34.2 and an EV to EBITDA of 24.36. Ambey Laborator.'s valuation appears stretched relative to these peers, highlighting its overvaluation status. Notably, over the past year, the stock has underperformed with a return of -39.55%, contrasting sharply with the Sensex's decline of only -2.97%.